✦ LIBER ✦

Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis

✍ Scribed by S. Bloom; S. Kiilerich; M. R. Lassen; A. Forbes; K. Leiper; E. Langholz; E. J. Irvine; C. O'Morain; D. Lowson; S. Orm

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, placebo-controlled trial of

✍ M.A. de Bièvre; A.A. Vrij; E.J. Schoon; G. Dijkstra; A.E. de Jong; A.H. Oberndor 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Oral, colonic-release low-molecular-weig

✍ L. PASTORELLI; S. SAIBENI; L. SPINA; C. SIGNORELLI; G. CELASCO; R. DE FRANCHIS; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Low-molecular-weight heparin (enoxaparin

✍ P. ZEZOS; G. PAPAIOANNOU; N. NIKOLAIDIS; K. PATSIAOURA; A. PAPAGEORGIOU; T. VASS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB